Three Arch Partners
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as
Business Model:
Revenue: $7.3M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Three Arch Partners Information
Geographic Data
Address: 3200 Alpine Rd
City: Portola Valley
State: CA
Zip: 94028
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.
Contact Phone:
+16505298000
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2011 | Inova Labs | Series B | 0 |
| 1/2005 | Reliant Technologies | Series C | 7M |
| 2/2004 | Reliant Technologies | Series B | 12.9M |
| 7/2002 | Visiogen | Series B | 5M |
| 1/2011 | VisionCare Ophthalmic Technologies | Series E | 0 |
| 7/2002 | Opus Medical | Series B | 6.5M |
| 6/2003 | Opus Medical | Series C | 13.6M |
| 11/2009 | Calibra Medical | Venture Round | 1.4M |
| 1/2004 | Threshold Pharmaceuticals | Series B | 41M |
| 11/2007 | SquareOne | Series C | 8M |
| 6/1997 | Spinal Dynamics | Series A | - |
| 3/2011 | Tibion Bionic Technologies | Series B | 0 |
| 3/2005 | Confluent Surgical | Series D | 0 |
| 4/2007 | Aspen MedTech | Venture Round | 1M |
| 1/2003 | Vascular Architects | Series D | 0 |
| 7/2008 | Eleme Medical | Series C | 0 |
| 3/2004 | Coalescent Surgical | Series E | 2M |
| 2/2009 | SpinalMotion | Venture Round | 500k |
| 5/2009 | iScience Interventional | Series F | 20.5M |
| 8/2006 | LipoScience | Series F | 13M |
| 3/2005 | Sirtris Pharmaceuticals | Series B | 27M |
| 1/2008 | Arbor Surgical Technologies | Series C | 0 |
| 4/2006 | Sirtris Pharmaceuticals | Series C | 37M |
| 3/2005 | SpinalMotion | Series B | 20.1M |
| 5/2007 | Pegasus Biologics | Series C | 20M |
| 7/2004 | LipoSonix | Series C | 27M |
| 3/2007 | SmoothShapes | Series B | 15M |
| 10/2007 | TriReme Medical | Series C | 15.5M |
| 6/2005 | Pegasus Biologics | Series B | 10M |
| 10/2004 | Concuity | Venture Round | 8.3M |
| 9/2008 | Baxano | Series B | 20M |
| 3/2010 | Access Closure | Venture Round | 10M |
| 7/2002 | Transvascular | Series D | 10.8M |
| 6/2002 | Spiration | Series D | 22M |
| 3/2005 | Neuronetics | Series B | 8.5M |
| 3/2005 | iScience Surgical | Series C | 0 |
| 8/2008 | Calibra Medical | Series B | 35M |
| 12/2006 | NBI Development | Seed Round | 5.5M |
| 10/2005 | Radiant Medical | Venture Round | 36M |
| 4/2010 | Hemosphere | Series A | 9.3M |
| 6/2010 | Voyage Medical | Series C | 20.6M |
| 8/2008 | Voyage Medical | Series B | 22M |
| 1/2008 | North American Scientific | Venture Round | 15.5M |
| 1/2012 | iScience Interventional | Venture Round | 2.8M |
| 9/2006 | Calibra Medical | Series A | 8.6M |
| 3/2007 | Ascend Health | Series B | 20.1M |
| 12/2006 | Respicardia | Series A | 5.5M |
| 7/2004 | Vitra Bioscience | Venture Round | 5.5M |
| 7/2010 | Ingenuity Systems | Venture Round | 15.4M |
| 3/2008 | Spiration | Series G | 18.5M |
| 6/2010 | Baxano | Series C | 30M |
| 1/2001 | Phylos | Series B | 25M |
| 11/2003 | The Center from Health Promotion | Venture Round | 10M |
| 5/2011 | Neuronetics | Series E | 30M |
| 12/2006 | Nevro | Seed Round | 5.5M |
| 7/2011 | Nevro | Series B | 58M |
| 9/2008 | Nevro | Series A | 21.8M |
| 4/2008 | Concert Pharmaceuticals | Series C | 0 |
| 6/2017 | Neuronetics | Series G | 0 |
| 1/2010 | Free &a; Clear | Venture Round | 10M |
| 4/2015 | Neuronetics | Series F | 0 |
| 9/2008 | APT Pharmaceuticals | Series B | 32M |
| 4/2006 | Spiration | Series F | 13.4M |
| 10/2008 | Respicardia | Series B | 0 |
| 6/2008 | Cameron Health | Series E | 0 |
| 7/2006 | Concert Pharmaceuticals | Series A | 10M |
| 5/2004 | Evalve | Series C | 0 |
| 3/2013 | Nevro | Series C | 0 |
| 1/2004 | Spiration | Series E | 0 |
| 3/2002 | Novacept | Venture Round | 30M |
| 3/2000 | MEDCHANNEL | Series B | 42M |
| 11/2013 | Ocera Therapeutics | Post-IPO Equity | 0 |
| 1/2007 | AcuFocus | Series D | 0 |
| 4/2007 | Reliant Technologies | Series E | 15M |
| 12/2002 | VetCentric | Venture Round | 14.5M |
| 1/2005 | VisionCare Ophthalmic Technologies | Series D | 20M |
| 5/2009 | Visiogen | Series D | 40M |
| 12/2003 | Visiogen | Venture Round | 16.5M |
| 11/2002 | Coalescent Surgical | Series D | 0 |
| 5/2008 | Novasys Medical, Inc. | Series D | 49.5M |
| 10/2005 | Cameron Health | Series C | 15M |
| 7/2006 | Cameron Health | Series D | 31M |
| 11/2006 | Concert Pharmaceuticals | Series B | 48.5M |
| 11/2012 | MEI Pharma | Post-IPO Equity | 27.5M |
| 7/2003 | VisionCare Ophthalmic Technologies | Series B | 6.8M |
| 4/2005 | Allux Medical | Series B | 5M |
| 5/2008 | Novasys Health | Venture Round | 49.5M |
| 1/2008 | Benvenue Medical | Series B | 15M |
| 11/2003 | Cameron Health | Series B | 29M |
| 4/2006 | Concuity | Series E | 2.5M |
| 1/2004 | NeuroVista | Series A | 7.3M |
| 3/2007 | SquareOne | Series C | 0 |
| 6/2005 | Pegasus Biologics | Series B | 10M |
| 6/2002 | Novare Surgical | Series C | 9.8M |
| 4/2003 | iScience Interventional | Series C | 15M |
| 3/2007 | Calistoga Pharmaceuticals | Series A | 21M |
| 5/2007 | Arete Therapeutics | Series A | 35M |
| 6/2010 | Calistoga Pharmaceuticals | Series C | 40M |
| 1/2008 | Calistoga Pharmaceuticals | Series A | 5.2M |
| 9/2004 | Vascular Architects | Series E | 0 |
| 6/2011 | Crux Biomedical | Series C | 12M |
| 1/2002 | Opus Medical | Series B | 2.1M |
| 8/2002 | Threshold Pharmaceuticals | Series A | 8.3M |
| 1/2012 | Access Closure | Venture Round | 0 |
| 2/2007 | Visiogen | Venture Round | 24M |
| 11/2003 | VisionCare Ophthalmic Technologies | Series C | 12.4M |
| 7/2007 | Satiety | Series D | 30M |
| 12/2004 | NeuroBionics | Series A | 6M |
| 9/2004 | Allux Medical | Series A | 800k |
| 8/2000 | Epocrates | Series B | 35M |
| 12/2005 | Oculir | Series A | 7.3M |
| 8/2002 | Epocrates | Series C | - |
| 4/2007 | iScience Interventional | Series E | 20M |
| 10/2010 | TriReme Medical | Series D | 17M |
| 5/2007 | Pegasus Biologics | Series C | 20M |
| 10/2011 | Salveo Specialty Pharmacy | Series A | - |
| 3/2006 | Reliant Technologies | Series D | 22M |
| 5/2007 | NeuroVista | Series B | 33.8M |
| 10/2012 | Access Closure | Venture Round | 0 |
| 8/2002 | Concuity | Series C | 16.3M |
| 10/2009 | Neuronetics | Series D | 0 |
| 8/2006 | Neuronetics | Series C | 0 |
| 8/2010 | Respicardia | Series C | 0 |
| 5/2009 | Calistoga Pharmaceuticals | Series B | 30M |
| 8/2003 | LipoScience | Series E | 15M |
| 6/2017 | Neuronetics | Series G | 0 |
| 4/2015 | Neuronetics | Series F | 0 |
| 11/2013 | Ocera Therapeutics | Post-IPO Equity | 0 |
| 3/2013 | Nevro | Series C | 0 |
| 11/2012 | MEI Pharma | Post-IPO Equity | 0 |
| 10/2012 | Access Closure | Venture Round | 0 |
| 1/2012 | iScience Interventional | Venture Round | 0 |
| 1/2012 | Access Closure | Venture Round | 0 |
| 11/2011 | Inova Labs | Series B | 0 |
| 10/2011 | Salveo Specialty Pharmacy | Series A | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
